Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-26

Clinical Trial Update: IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid Hemorrhage [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intra-arterial lidocaine and methylprednisolone for headaches associated with subarachnoid hemorrhage; status is not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine (Lidocaine)
  • METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Daniel Raper, MBBS | Conditions: Headaches Associated With Subarachnoid Hemorrhage (SAH) | Phase 2 | Status: NOT_YET_RECRUITING